The University of Southampton
University of Southampton Institutional Repository

Skin manifestations of drug allergy

Skin manifestations of drug allergy
Skin manifestations of drug allergy
Cutaneous adverse drug reactions range from mild to severe and from those localized only to skin to those associated with systemic disease. It is important to distinguish features of cutaneous drug reactions which help classify the underlying mechanism and likely prognosis as both of these influence management decisions, some of which necessarily have to be taken rapidly. Severe cutaneous reactions are generally T cell-mediated, yet this immunological process is frequently poorly understood and principles for identification of the culprit drug are different to those of IgE mediated allergic reactions. Furthermore, intervention in severe skin manifestations of drug allergy is frequently necessary. However, a substantial literature reports on success or otherwise of glucocorticoids, cyclophsphamide, ciclosporin, intravenous immunoglobulin and anti-tumour necrosis factor therapy for the treatment of toxic epidermal necrolysis without clear consensus. As well as reviewing the recommended supportive measures and evidence base for interventions, this review aims to provide a mechanistic overview relating to a proposed clinical classification to assist the assessment and management of these complex patients.
adverse drug reaction, drug allergy, skin, toxic epidermal necrolysis
0007-1188
672-683
Ardern-Jones, Michael R.
7ac43c24-94ab-4d19-ba69-afaa546bec90
Friedmann, Peter S.
d50bac23-f3ec-4493-8fa0-fa126cbeba88
Ardern-Jones, Michael R.
7ac43c24-94ab-4d19-ba69-afaa546bec90
Friedmann, Peter S.
d50bac23-f3ec-4493-8fa0-fa126cbeba88

Ardern-Jones, Michael R. and Friedmann, Peter S. (2010) Skin manifestations of drug allergy. British Journal of Pharmacology, 71 (5), 672-683. (doi:10.1111/j.1365-2125.2010.03703.x). (PMID:21480947)

Record type: Article

Abstract

Cutaneous adverse drug reactions range from mild to severe and from those localized only to skin to those associated with systemic disease. It is important to distinguish features of cutaneous drug reactions which help classify the underlying mechanism and likely prognosis as both of these influence management decisions, some of which necessarily have to be taken rapidly. Severe cutaneous reactions are generally T cell-mediated, yet this immunological process is frequently poorly understood and principles for identification of the culprit drug are different to those of IgE mediated allergic reactions. Furthermore, intervention in severe skin manifestations of drug allergy is frequently necessary. However, a substantial literature reports on success or otherwise of glucocorticoids, cyclophsphamide, ciclosporin, intravenous immunoglobulin and anti-tumour necrosis factor therapy for the treatment of toxic epidermal necrolysis without clear consensus. As well as reviewing the recommended supportive measures and evidence base for interventions, this review aims to provide a mechanistic overview relating to a proposed clinical classification to assist the assessment and management of these complex patients.

This record has no associated files available for download.

More information

Published date: May 2010
Keywords: adverse drug reaction, drug allergy, skin, toxic epidermal necrolysis

Identifiers

Local EPrints ID: 146333
URI: http://eprints.soton.ac.uk/id/eprint/146333
ISSN: 0007-1188
PURE UUID: 9bbd0361-77ad-4e65-96f3-143fa3495603
ORCID for Michael R. Ardern-Jones: ORCID iD orcid.org/0000-0003-1466-2016

Catalogue record

Date deposited: 21 Apr 2010 13:20
Last modified: 14 Mar 2024 02:52

Export record

Altmetrics

Contributors

Author: Peter S. Friedmann

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×